NNBP — Nanobac Pharmaceuticals Balance Sheet
0.000.00%
Last trade - 00:00
HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $4.12m
- $0.02m
2003 December 31st | 2004 December 31st | 2005 December 31st | 2006 December 31st | 2007 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10KSB/A | 10KSB/A | 10KSB | 10KSB | 10KSB |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.05 | 0.018 | 0.009 | 0.04 | 0.004 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 0.006 | 0.003 | 0.003 | 0.001 | 0.002 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 0.087 | 0.116 | 0.174 | 0.127 | 0.031 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 0.137 | 0.126 | 0.108 | 0.061 | 0.038 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 8.25 | 9.69 | 8.97 | 7.83 | 7.22 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 6.85 | 1.3 | 3.67 | 6.3 | 6.75 |
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 9.05 | 3.57 | 6.51 | 9.14 | 9.58 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -0.807 | 6.11 | 2.46 | -1.31 | -2.36 |
Total Liabilities & Shareholders' Equity | 8.24 | 9.68 | 8.97 | 7.83 | 7.22 |
Total Common Shares Outstanding | |||||
Total Preferred Shares Outstanding |